;

Product Development

September 18, 2019
Innovation at REV.1 Engineering

REV•1 Engineering® Takes Early Phase Medical Device Development To The Next Level

It’s been a while since my last blog, as it’s been a busy summer here at REV•1 Engineering®.  Things have been so busy, our team has grown by 30% since the beginning of the year.  Not only have we been expanding our team of exceptional knowledge workers, we’ve added another compelling resource to the company; a Hewlett Packard Multi Jet Fusion 580 additive manufacturing system. If you’re unfamiliar with this technology (https://www8.hp.com/us/en/printers/3d-printers.html), it’s a real […]
July 29, 2019

REV•1 Engineering® Named As Exclusive Development Partner For Valvublator

Leonhardt Ventures taps REV•1 Engineering to design and develop Valvublator’s heart valve regeneration technology platform. MURRIETA, Calif. – July 26, 2019 – REV•1 Engineering has been selected as the exclusive design and development partner for the commercialization of Valvublator’s advanced, combination drug/device/biologics technology for regenerating human heart valves.  Valvublator’s platform integrates mechanical, electrical, therapeutical, and biological elements in a single, minimally invasive catheter to decalcify, cell sod and regenerate a patient’s heart valve leaflets.  It is intended […]
July 29, 2019

How Design For Manufacturing Can Effect Company Valuation At Exit

Throughout a medical device’s Life Cycle, few opportunities ever afford themselves to the organization to initiate a strategic approach to Design for Manufacturing in order to optimize product profitability.  This is especially true for companies navigating the transition from clinical stage to commercial stage operations.  The pressure to get to market and begin generating revenue is fierce.  A device that has successfully cleared FDA/secured CE mark, and demonstrated its merits in clinical studies, is going […]
May 30, 2019
REV.1 Engineering catheter device development.

Developing Medical Devices in an Age of Reimbursement Uncertainty

Developing advanced medical devices is challenging enough even during the most predictable of times.  Today, we’re still in mid-migration, from the traditional, fee-for-service system to a value-based reimbursement system.  Simultaneously, a noteworthy percentage of our nation’s electorate and presidential candidates are debating various versions of a single payer system.  Our industry cousins in the pharmaceutical trades are also finding their pricing coming under greater scrutiny.  Yet, with change comes opportunity. I believe it can be […]
X
Schedule a Conversation
Contact Us